Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Cash from Investing Activities (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Cash from Investing Activities for 16 consecutive years, with -$599000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 28.54% to -$599000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.9 million through Dec 2025, down 38.62% year-over-year, with the annual reading at -$1.9 million for FY2025, 38.62% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$599000.0 at Harvard Bioscience, down from -$348000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $458000.0 in Q2 2024, with the low at -$1.1 million in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$397050.0, with a median of -$421500.0 recorded in 2022.
  • The sharpest move saw Cash from Investing Activities tumbled 351.49% in 2023, then soared 173.28% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$358000.0 in 2021, then surged by 34.36% to -$235000.0 in 2022, then crashed by 351.49% to -$1.1 million in 2023, then soared by 56.08% to -$466000.0 in 2024, then decreased by 28.54% to -$599000.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$599000.0, -$348000.0, and -$233000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.